Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

MicroRNA expression patterns related to merkel cell polyomavirus infection in human merkel cell carcinoma.

Xie H, Lee L, Caramuta S, Höög A, Browaldh N, Björnhagen V, Larsson C, Lui WO.

J Invest Dermatol. 2014 Feb;134(2):507-517. doi: 10.1038/jid.2013.355. Epub 2013 Aug 20.

2.

Mechanisms of p53 restriction in Merkel cell carcinoma cells are independent of the Merkel cell polyoma virus T antigens.

Houben R, Dreher C, Angermeyer S, Borst A, Utikal J, Haferkamp S, Peitsch WK, Schrama D, Hesbacher S.

J Invest Dermatol. 2013 Oct;133(10):2453-2460. doi: 10.1038/jid.2013.169. Epub 2013 Apr 5.

3.

The Merkel cell polyomavirus and its involvement in Merkel cell carcinoma.

Amber K, McLeod MP, Nouri K.

Dermatol Surg. 2013 Feb;39(2):232-8. doi: 10.1111/dsu.12079. Review.

PMID:
23387356
4.

miRNA-34a underexpressed in Merkel cell polyomavirus-negative Merkel cell carcinoma.

Veija T, Sahi H, Koljonen V, Bohling T, Knuutila S, Mosakhani N.

Virchows Arch. 2015 Mar;466(3):289-95. doi: 10.1007/s00428-014-1700-9. Epub 2014 Dec 10.

PMID:
25491743
5.

Identification and validation of a novel mature microRNA encoded by the Merkel cell polyomavirus in human Merkel cell carcinomas.

Lee S, Paulson KG, Murchison EP, Afanasiev OK, Alkan C, Leonard JH, Byrd DR, Hannon GJ, Nghiem P.

J Clin Virol. 2011 Nov;52(3):272-5. doi: 10.1016/j.jcv.2011.08.012. Epub 2011 Sep 9.

6.

Survivin is a therapeutic target in Merkel cell carcinoma.

Arora R, Shuda M, Guastafierro A, Feng H, Toptan T, Tolstov Y, Normolle D, Vollmer LL, Vogt A, Dömling A, Brodsky JL, Chang Y, Moore PS.

Sci Transl Med. 2012 May 9;4(133):133ra56. doi: 10.1126/scitranslmed.3003713.

7.

Hotspot mutations in polyomavirus positive and negative Merkel cell carcinomas.

Veija T, Sarhadi VK, Koljonen V, Bohling T, Knuutila S.

Cancer Genet. 2016 Jan-Feb;209(1-2):30-5. doi: 10.1016/j.cancergen.2015.11.006. Epub 2015 Dec 4.

PMID:
26725423
8.

Distinct gene expression profiles of viral- and nonviral-associated merkel cell carcinoma revealed by transcriptome analysis.

Harms PW, Patel RM, Verhaegen ME, Giordano TJ, Nash KT, Johnson CN, Daignault S, Thomas DG, Gudjonsson JE, Elder JT, Dlugosz AA, Johnson TM, Fullen DR, Bichakjian CK.

J Invest Dermatol. 2013 Apr;133(4):936-45. doi: 10.1038/jid.2012.445. Epub 2012 Dec 6.

9.

Clonal integration of a polyomavirus in human Merkel cell carcinoma.

Feng H, Shuda M, Chang Y, Moore PS.

Science. 2008 Feb 22;319(5866):1096-100. doi: 10.1126/science.1152586. Epub 2008 Jan 17.

10.

Merkel cell polyomavirus-infected Merkel cell carcinoma cells require expression of viral T antigens.

Houben R, Shuda M, Weinkam R, Schrama D, Feng H, Chang Y, Moore PS, Becker JC.

J Virol. 2010 Jul;84(14):7064-72. doi: 10.1128/JVI.02400-09. Epub 2010 May 5.

11.

Merkel cell carcinoma: recent insights and new treatment options.

Schrama D, Ugurel S, Becker JC.

Curr Opin Oncol. 2012 Mar;24(2):141-9. doi: 10.1097/CCO.0b013e32834fc9fe. Review.

PMID:
22234254
12.

Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors.

Shuda M, Arora R, Kwun HJ, Feng H, Sarid R, Fernández-Figueras MT, Tolstov Y, Gjoerup O, Mansukhani MM, Swerdlow SH, Chaudhary PM, Kirkwood JM, Nalesnik MA, Kant JA, Weiss LM, Moore PS, Chang Y.

Int J Cancer. 2009 Sep 15;125(6):1243-9. doi: 10.1002/ijc.24510.

13.

Prospective study of Merkel cell polyomavirus and risk of Merkel cell carcinoma.

Faust H, Andersson K, Ekström J, Hortlund M, Robsahm TE, Dillner J.

Int J Cancer. 2014 Feb 15;134(4):844-8. doi: 10.1002/ijc.28419. Epub 2013 Aug 29.

14.

Bcl-2 expression indicates better prognosis of Merkel cell carcinoma regardless of the presence of Merkel cell polyomavirus.

Sahi H, Koljonen V, Kavola H, Haglund C, Tukiainen E, Sihto H, Böhling T.

Virchows Arch. 2012 Nov;461(5):553-9. doi: 10.1007/s00428-012-1310-3. Epub 2012 Sep 14.

PMID:
22976527
15.

Merkel cell polyomavirus status is not associated with clinical course of Merkel cell carcinoma.

Schrama D, Peitsch WK, Zapatka M, Kneitz H, Houben R, Eib S, Haferkamp S, Moore PS, Shuda M, Thompson JF, Trefzer U, Pföhler C, Scolyer RA, Becker JC.

J Invest Dermatol. 2011 Aug;131(8):1631-8. doi: 10.1038/jid.2011.115. Epub 2011 May 12.

16.

Response of Merkel cell polyomavirus-positive merkel cell carcinoma xenografts to a survivin inhibitor.

Dresang LR, Guastafierro A, Arora R, Normolle D, Chang Y, Moore PS.

PLoS One. 2013 Nov 18;8(11):e80543. doi: 10.1371/journal.pone.0080543. eCollection 2013.

17.

Merkel cell polyomavirus-positive Merkel cell carcinoma cells do not require expression of the viral small T antigen.

Angermeyer S, Hesbacher S, Becker JC, Schrama D, Houben R.

J Invest Dermatol. 2013 Aug;133(8):2059-64. doi: 10.1038/jid.2013.82. Epub 2013 Feb 25.

18.

Lack of evidence for basal or squamous cell carcinoma infection with Merkel cell polyomavirus in immunocompetent patients with Merkel cell carcinoma.

Reisinger DM, Shiffer JD, Cognetta AB Jr, Chang Y, Moore PS.

J Am Acad Dermatol. 2010 Sep;63(3):400-3. doi: 10.1016/j.jaad.2009.08.064. Epub 2010 Jun 26.

PMID:
20584559
19.

Characterization of an early passage Merkel cell polyomavirus-positive Merkel cell carcinoma cell line, MS-1, and its growth in NOD scid gamma mice.

Guastafierro A, Feng H, Thant M, Kirkwood JM, Chang Y, Moore PS, Shuda M.

J Virol Methods. 2013 Jan;187(1):6-14. doi: 10.1016/j.jviromet.2012.10.001. Epub 2012 Oct 18.

20.

Merkel cell polyomavirus infection, large T antigen, retinoblastoma protein and outcome in Merkel cell carcinoma.

Sihto H, Kukko H, Koljonen V, Sankila R, Böhling T, Joensuu H.

Clin Cancer Res. 2011 Jul 15;17(14):4806-13. doi: 10.1158/1078-0432.CCR-10-3363. Epub 2011 Jun 3.

Supplemental Content

Support Center